THE LIMITED VALUE OF ROUTINE CHEST-X-RAY IN THE FOLLOW-UP OF STAGE-II BREAST-CANCER

被引:29
|
作者
LOGAGER, VB
VESTERGAARD, A
HERRSTEDT, J
THOMSEN, HS
ZEDELER, K
DOMBERNOWSKY, P
机构
[1] UNIV COPENHAGEN,HERLEV HOSP,DEPT ONCOL,DK-2730 HERLEV,DENMARK
[2] UNIV COPENHAGEN,HERLEV HOSP,DEPT NUCL MED,DK-2730 HERLEV,DENMARK
[3] UNIV COPENHAGEN HOSP,FINSEN INST,DK-2100 COPENHAGEN,DENMARK
关键词
D O I
10.1016/0277-5379(90)90073-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In 280 patients with stage II breast cancer, chest X-ray was performed at 6 and 12 months and yearly thereafter to the 6th year or until recurrence, another cancer was detected, the patient refused further follow-up or died. Among 1289 scheduled chest X-rays, malignant changes were found in 20 patients, of which only 3 had pulmonary symptoms. In a further 14 patients malignant changes were suspected, but follow-up examinations could not prove malignancy. 26 patients presented within 12 months after the last scheduled X-ray with pulmonary symptoms and a work-up chest X-ray revealed malignant changes. Thus, in only 1.3% of the scheduled X-rays were unsuspected malignant changes diagnosed. Median survival of patients with malignant chest X-rays found at scheduled controls versus between scheduled controls did not differ significantly (P = 0.26). It is concluded that routine chest X-ray is not indicated in patients with stage II breast cancer. © 1990.
引用
收藏
页码:553 / 555
页数:3
相关论文
共 50 条
  • [31] THE VALUE OF ROUTINE CHEST-X-RAY AFTER BRONCHOSCOPY IN ELDERLY VENTILATED PATIENTS
    AGGARWAL, V
    KUPFER, YY
    TESSLER, S
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1995, 43 (09) : SA27 - SA27
  • [32] ADJUVANT TAMOXIFEN THERAPY IN STAGE-II BREAST-CANCER
    MARSHALL, JS
    HUBAY, CA
    PEARSON, OH
    GORDON, N
    CROWE, J
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1985, 6 (02) : 167 - 167
  • [33] FREQUENT CHEST-X-RAY FLUOROSCOPY AND BREAST-CANCER INCIDENCE AMONG TUBERCULOSIS PATIENTS IN MASSACHUSETTS
    BOICE, JD
    PRESTON, D
    DAVIS, FG
    MONSON, RR
    [J]. RADIATION RESEARCH, 1991, 125 (02) : 214 - 222
  • [34] FOLLOW-UP OF OPERABLE BREAST-CANCER - VALUE OF LABORATORY SCREENING
    SIMADER, H
    HAUSMANINGER, H
    MLINERITSCH, B
    [J]. BLUT, 1986, 53 (03): : 136 - 136
  • [35] VALUE OF LABORATORY DIAGNOSIS IN FOLLOW-UP OF BREAST-CANCER PATIENTS
    SCHMIDTRHODE, P
    FRIEBE, M
    ZWIOREK, L
    SCHULZ, KD
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 814 - 816
  • [36] POST-TREATMENT FOLLOW-UP OF STAGE-II NONSEMINOMATOUS TESTICULAR CANCER
    HIGGINS, MC
    TORTI, FM
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 129 - 129
  • [37] REPLACEMENT ESTROGEN THERAPY AND STAGE-II BREAST-CANCER
    GREENSPAN, EM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (18): : 2425 - 2425
  • [38] POST-TREATMENT FOLLOW-UP OF STAGE-II NONSEMINOMATOUS TESTICULAR CANCER
    HIGGINS, MC
    MARTON, KI
    [J]. CLINICAL RESEARCH, 1983, 31 (01): : A67 - A67
  • [39] NEU-PROTEIN OVEREXPRESSION IN BREAST-CANCER - ASSOCIATION WITH COMEDO-TYPE DUCTAL CARCINOMA INSITU AND LIMITED PROGNOSTIC VALUE IN STAGE-II BREAST-CANCER
    VANDEVIJVER, MJ
    PETERSE, JL
    MOOI, WJ
    WISMAN, P
    LOMANS, J
    DALESIO, O
    NUSSE, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (19): : 1239 - 1245
  • [40] ANTIESTROGEN-CYTOTOXIC CHEMOTHERAPY AND BACILLUS CALMETTE-GUERIN VACCINATION IN STAGE-II BREAST-CANCER - 72-MONTH FOLLOW-UP
    HUBAY, CA
    GORDON, NH
    CROWE, JP
    GUYTON, SP
    PEARSON, OH
    MARSHALL, JS
    MANSOUR, EG
    HERMANN, RE
    JONES, JC
    FLYNN, WJ
    ECKERT, C
    SPONZO, RW
    MCGUIRE, WL
    EVANS, D
    [J]. SURGERY, 1984, 96 (01) : 61 - 72